insulin glulisine
insulin glulisine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Apidra, Apidra SoloStar. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin glulisine
- Brand Names
- Apidra, Apidra SoloStar
- Application Number
- BLA021629
- Sponsor
- sanofi-aventis U.S. LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- INSULIN GLULISINE
Indications and Usage
1 INDICATIONS AND USAGE APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. APIDRA is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )